North America
South America
Australia & New Zealand
Europe
Middle East / Africa
Asia / Pacific
×
×
Purified Mouse Anti-Human IFN-γ B27 RUO

Purified Mouse Anti-Human IFN-γ 

Clone  B27   (RUO)

  • Brand BD Pharmingen™
  • Alternative Name IFNG; Interferon-gamma; Interferon-γ; Type II interferon; MAF
  • Concentration 0.5 mg/ml
  • Isotype Mouse IgG1, κ
  • Reactivity Human (QC Testing)  Rhesus, Cynomolgus, Baboon (Tested in Development) 
  • Application ELISA (Routinely Tested) 
    Neutralization, Blocking (Tested During Development) 
    Immunoprecipitation (Reported) 
  • Immunogen Human IFN-γ Recombinant Protein
  • Storage Buffer Aqueous buffered solution containing ≤0.09% sodium azide.
  • Regulatory Status RUO
Product Details Recommended Assay References

Description

The B27 monoclonal antibody specifically binds to human interferon-γ (IFN-γ), a 14-18 kDa glycoprotein containing 143 amino acid residues. IFN-γ is a potent multifunctional cytokine produced by several activated cell types including NK, NKT, CD4+TCRαβ+, CD8+TCRαβ+, and TCRγδ+ T cells. IFN-γ exerts its biological effects through specific binding to the high-affinity IFN-γ receptor complex comprised of IFN-γRα (CD119) and IFN-γRβ subunits. In addition to its antiviral effects, IFN-γ upregulates a number of lymphoid cell functions including the antimicrobial and anti-tumor responses of macrophages, NK cells, and neutrophils. In addition, IFN-γ influences the regulation of proliferation, differentiation, and effector responses of B cell and T cell subsets. These influences can involve IFN-γ's capacity to boost MHC class I and II expression by antigen-presenting cells as well as direct effects on B cells and T cells themselves. B27 is a neutralizing antibody. The use of B27 antibody for epitope mapping of human IFN-γ has been described. The B27 antibody has been reported not to bind to denatured IFN-γ.

Format
  • Format Purified

Other Formats →

Suggested Companion Products

PE Mouse Anti-Human IFN-γ B27 RUO
0.1 mg Cat No: 554701

Purified NA/LE Mouse Anti-Human IFN-γ B27 RUO
0.5 mg Cat No: 554698

Stain Buffer (FBS) RUO
500 mL Cat No: 554656

Stain Buffer (BSA) RUO
500 mL Cat No: 554657

Purified Mouse Anti-Human IFN-γ B27 RUO
0.25 mg Cat No: 550011

PE-Cy™5 Mouse Anti-Human CD3 UCHT1 (also known as UCHT-1; UCHT 1) RUO
100 Tests Cat No: 555334

Protein Transport Inhibitor (Containing Monensin) RUO
0.7 mL Cat No: 554724

PE-Cy™5 Mouse Anti-Human CD3 UCHT1 (also known as UCHT-1; UCHT 1) RUO
25 Tests Cat No: 561007

BD Cytofix/Cytoperm Plus Kit (with BD GolgiStop) RUO
250 Tests Cat No: 554715

PE Mouse Anti-Human IFN-γ B27 RUO
100 Tests Cat No: 559327

Resources & Tools
 Spectrum Viewer  Download TDS  Regulatory Document Website
Preparation and Storage

Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. An isotype control should be used at the same concentration as the antibody of interest.
  3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  4. Sodium azide is a reversible inhibitor of oxidative metabolism; therefore, antibody preparations containing this preservative agent must not be used in cell cultures nor injected into animals. Sodium azide may be removed by washing stained cells or plate-bound antibody or dialyzing soluble antibody in sodium azide-free buffer. Since endotoxin may also affect the results of functional studies, we recommend the NA/LE (No Azide/Low Endotoxin) antibody format, if available, for in vitro and in vivo use.
  5. Cy is a trademark of GE Healthcare.
  6. Please refer to www.bdbiosciences.com/pharmingen/protocols for technical protocols.


Blocking Control for Intracellular Staining: The purified B27 antibody can be used as a blocking control to demonstrate specificity of IFN-γ

staining by PE-B27 antibody or FITC-B27 antibody (Cat. No. 554701/554700). To perform this control, the fixed/permeabilized cells (~1

million) can be incubated with 1-10 µg of unlabeled B27 antibody (Cat. No. 554669) for 20 minutes at 4°C, prior to staining with PE-B27

antibody or FITC-B27 antibody (e.g., 0.1-0.5 µg mAb/1 million cells). The intracellular cytokine staining technique and use of blocking controls

are described in detail by C. Prussin and D. Metcalfe.

Neutralization: The NA/LE™ B27 antibody is useful for neutralization of human IFN-γ bioactivity. This purified B27 antibody (Cat. No. 554698) is supplied in sodium azide free, sterile-filtered (0.22 µm pore) PBS, pH 7.2. Endotoxin level as determined by LAL assay is less than 0.01 ng/µg protein.

IP/WB: The B27 antibody has been reported to be useful for immunoprecipitation studies. The B27 antibody has been reported not to bind to denatured IFN-γ.


  1. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992; 127:5-24. View reference

  2. Favre C, Wijdenes J, Cabrillat H, Djossou O, Banchereau J, de Vries JE. Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. Mol Immunol. 1989; 26(1):17-25. View reference

  3. Fonteneau JF, Le Drean E, Le Guiner S, Gervois N, Diez E, Jotereau F. Heterogeneity of biologic responses of melanoma-specific CTL. J Immunol. 1997; 159(6):2831-2839. View reference

  4. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995; 188(1):117-128. View reference

  5. Rotteveel FT, Kokkelink I, van Lier RA, et al. Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med. 1988; 168(5):1659-1673. View reference

554699 Rev. 5
Instruments
Reagents
Applications
Sales & Support
BD BioSciences